RAPHAEL Horizon Europe’s Post

Science System Advisory Group (SSAG) review for NZ One of the initiatives that the Hon Judith Collins has been central in getting moving is a wide ranging review into the science and innovation potential across the motu and the barriers to moving forward. These opportunities need to be taken and are a chance for our industry and those involved across the science sectors to outline the challenges but also to come up with the solutions to take advantage of the undoubted ability within our science community. From a medical science perspective the current fragmented and difficult regulatory and competitive funding environment makes translational research to diagnostics a very difficult proposition. Many of us live and breath the barriers every day under the constraints that hold back so much potential positive advancement across the health sector. This is a perfect opportunity for individuals and industry stakeholders to identify the barriers and put solutions in front of the review committee. I encourage strong evidence based submissions with examples of how to progress your current challenges. This is not designed as a whinge fest but obviously honesty and truth around the current barriers will help the review panel to assess the current state to get a feel for the situation and the pathway to best harness and utilise the ability within our science sectors. These opportunities to be part of such a high profile review need to be taken. The initial submissions close on May 17th so make sure you all get your say! - Science System Advisory Group (ssag.org.nz)

We know that adoption of new technologies can be tricky, and we know there's sometimes resistance from health professionals. But why? Our new paper - link below👇 - focuses on 'impure innovation', taking a close look at how health professionals in 'dual roles' can feel stigmatised when they are involved in digital innovation. Drawing on interviews in the UK and Germany, we explain how individual professionals experience different intensities of stigmatization from colleagues when working with digital innovations. And we go on to theorize that the more central a dual-role professional is within an organization, and the more their innovation deviates from standard professional duties, the more likely the innovation is to be viewed as impure within a professional group and be the target of stigmatization. The good news? We also identified various professional, social, and personal strategies that dual-role innovators can adopt to manage their experiences of stigmatization and potentially progress innovation.

At IMG Research Academy, we help researchers focus on studies that make a real difference in healthcare. Submit your research today and be a catalyst for positive change in the field of science! #MiamiFlorida #ClinicalResearch #MedicalResearch

Funding opportunity: AI-driven evidence synthesis for policymaking from the Economic and Social Research Council (ESRC) Apply for funding to develop and administer a global evidence synthesis infrastructure to transform the evidence ecosystem. This infrastructure will provide policymakers with access to accurate, up-to-date, and accessible syntheses of existing scientific evidence in key policy areas. It will develop researcher and AI-driven capabilities and work collaboratively with national and international policymakers to produce timely evidence syntheses. You must be based at a UK research organisation eligible for ESRC funding. The full economic cost (FEC) of your project can be up to a maximum of £11.5 million. ESRC will fund up to £9.2 million. The project will start by 1 September 2025 and run for five years. https://buff.ly/4gA9w8K At Capti Innovation our mission is to make grant funding more accessible. Every year, we help hundreds of companies save time, win funding and accelerate growth by leveraging our extensive expertise in funding opportunities. Email us for more information hello@capti.co.uk #funding #investing #fintech #technology #sustainability #growth #cybersecurity #environment #food #automation #automotive #recycling #nutrition #medicine #robotics #farming #augmentedreality #neuroscience #grants #ukgrants #startupgrants #businessgrants #ukgovernmentgrant #sme #smegrant #businessfunding #smefunding #technologygrant #innovationgrant #capti #captiinnovation #gamechanging #gamechanginginnovation #disruptiveinnovation #smartgrant #ai #manufacturing #sustainable #innovation #telecoms #semiconductors #business #IUK #InnovateUK #SmartGrant #InnovateUKfunding

Although sounds like a new concept, Implementation Science has actually been practiced for a long time. From healthcare interventions to organizational change, Implementation Science drives real-world impact by translating research into action. #healthinnovation #research #translationalresearch #implementationscience

How do we make decisions as people, as organizations, as countries? The just-ended Evidence to Action Conference, held by International Centre for Evaluation and Development (ICED) in collaboration with Feed the Future MRR Innovation Lab and co-hosted by ISSER UG, shed light on how to make decisions based on the evidence available (Existing literature). This is an objective and unbiased way of decision making. Evidence-based decision making, as it is called, is applicable in all sectors: the public sector, private sector and sometimes even in our personal lives! #E2A #Evidencebased #Networking Featured in the picture below: Sheila Agyemang Oppong (Ph.D) Fatu Badiane PhD, Miriam Oppong

We have identified and focus on four broad scientific areas where we see potential for high impact advances in both our understanding of and treatment development for #misophonia. Those four areas are: 1. Focus on interdisciplinary science and collaboration 2. Build a fundamental understanding of misophonia 3. Support the development of diagnostic tools 4. Drive increased rigor in misophonia clinical studies To learn more details and why we focus on these areas, visit: https://lnkd.in/gq9ryP3j

Funding opportunity: AI-driven evidence synthesis for policymaking from the Economic and Social Research Council (ESRC) Apply for funding to develop and administer a global evidence synthesis infrastructure to transform the evidence ecosystem. This infrastructure will provide policymakers with access to accurate, up-to-date, and accessible syntheses of existing scientific evidence in key policy areas. It will develop researcher and AI-driven capabilities and work collaboratively with national and international policymakers to produce timely evidence syntheses. You must be based at a UK research organisation eligible for ESRC funding. The full economic cost (FEC) of your project can be up to a maximum of £11.5 million. ESRC will fund up to £9.2 million. The project will start by 1 September 2025 and run for five years. https://buff.ly/4gA9w8K At Capti Innovation our mission is to make grant funding more accessible. Every year, we help hundreds of companies save time, win funding and accelerate growth by leveraging our extensive expertise in funding opportunities. Email us for more information hello@capti.co.uk #funding #investing #fintech #technology #sustainability #growth #cybersecurity #environment #food #automation #automotive #recycling #nutrition #medicine #robotics #farming #augmentedreality #neuroscience #grants #ukgrants #startupgrants #businessgrants #ukgovernmentgrant #sme #smegrant #businessfunding #smefunding #technologygrant #innovationgrant #capti #captiinnovation #gamechanging #gamechanginginnovation #disruptiveinnovation #smartgrant #ai #manufacturing #sustainable #innovation #telecoms #semiconductors #business #IUK #InnovateUK #SmartGrant #InnovateUKfunding

Building strong, lasting partnerships is essential in #ImpSci. Take a look at this new report by The Academy of Medical Sciences on “Bolstering UK Health and Life Sciences Innovation through Cross-Sector Collaboration.” The report found four key themes to promote cross-sector collaboration: • Build blocks for effective cross-sector collaboration • Create an enabling environment for cross-sector collaboration • Improve access to health datasets • Build skills and capacity Read the full report: https://lnkd.in/eJUBKwUz

We congratulate Stefan Gaillard and Martijn van der Meer who have been listed in the Forbes 30 under 30 list for Science and Healthcare in Europe, in recognition of co-founding the Journal of Trial and Error. The Journal of Trial and Error was established in 2018 by Stefan and Martijn, together with fellow students of the History and Philosophy of Science master programme here at the Freudenthal Institute/UU. The independent diamond open-access journal redefines failure and rethinks scientific success – and currently has four issues published and a readership of 16,000+ people. The Journal of Trial and Error aims to close the gap between what is researched and what is published. Researchers are encouraged to publish ‘’failing’’ results, as those can actually be very useful for other scientists - if only to prevent other researchers from making the same mistake again. Read more here: https://lnkd.in/eXxuDG_8 #science #journal #30under30 #philosophyofscience #failure #sharingscience #openscience #research